MicroRNA‑195 inhibits epithelial‑mesenchymal transition by targeting G protein‑coupled estrogen receptor 1 in endometrial carcinoma

Deng,Junfeng; Wang,Weihua; Yu,Guangyu; Ma,Xiuzhen

doi:10.3892/mmr.2019.10652

MicroRNA‑195 inhibits epithelial‑mesenchymal transition by targeting G protein‑coupled estrogen receptor 1 in endometrial carcinoma

Authors:
- Junfeng Deng
- Weihua Wang
- Guangyu Yu
- Xiuzhen Ma
View Affiliations

Affiliations: Department of Obstetrics and Gynecology, Yantai Hospital of Traditional Chinese Medicine, Yantai, Shandong 264012, P.R. China
Published online on: September 6, 2019 https://doi.org/10.3892/mmr.2019.10652
Pages: 4023-4032
Copyright: © Deng et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Epithelial‑mesenchymal transition (EMT) has been shown to exert promoting effects on the progression of a number of cancer types, including endometrial carcinoma (EC). MicroRNA (miRNA or miR)‑195 has been shown to function as a tumor suppressor. This study aimed to explore the potential role of miR‑195 in the EMT process of EC. miR‑195 overexpression (Mimics) and mimics control (Mock) vectors were constructed and transfected into human endometrial cancer cells (AN3‑CA and Hec1A) using Lipofectamine 2000, and cell viability was detected using the Cell Counting kit‑8 (CCK‑8). The invasive and migratory capacities of the cells transfected with the Mimics or Mock vectors were assessed by Transwell and wound healing assays. Relative mRNA and protein levels were analyzed by reverse transcription‑quantitative polymerase chain reaction (RT‑qPCR) and western blot analysis, respectively. Using TargetScan prediction, the potential target of miR‑195 was identified and was further verified by dual‑luciferase reporter assay. Following transfection with miR‑195 mimics, the viability of the AN3‑CA and Hec1A cells decreased in a time‑dependent manner, specifically at 24 h. The wound closure rate and the number of invaded cells in the Mimics group were much lower than those in the Control and Mock groups (P<0.01). miR‑195 overexpression significantly upregulated the mRNA and protein levels of tissue inhibitor of metalloproteinase 2 (TIMP‑2), while it downregulated the expression levels of matrix metalloproteinase (MMP)‑2 and MMP‑9. Moreover, the phosphorylation levels of PI3K and AKT were also notably decreased (P<0.01). G protein‑coupled estrogen receptor 1 (GPER) was identified as a target of miR‑195. On the whole, the findings of this study indicate that the inhibitory effects of miR195 on EC cell migration and invasion are associated with the PI3K/AKT signaling pathway and GPER expression.

View Figures

View References

1	Zhang G, Cheng Y, Zhang Q, Li X, Zhou J, Wang J and Wei L: ATX-LPA axis facilitates estrogen-induced endometrial cancer cell proliferation via MAPK/ERK signaling pathway. Mol Med Rep. 17:4245–4252. 2018.PubMed/NCBI
2	Siegel RL, Miller KD and Jemal A: Cancer Statistics, 2017. CA Cancer J Clin. 67:7–30. 2017. View Article : Google Scholar : PubMed/NCBI
3	Ward KK, Shah NR, Saenz CC, McHale MT, Alvarez EA and Plaxe SC: Cardiovascular disease is the leading cause of death among endometrial cancer patients. Gynecol Oncol. 126:176–179. 2012. View Article : Google Scholar : PubMed/NCBI
4	Elit L and Hirte H: Novel strategies for systemic treatment of endometrial cancer. Expert Opin Investig Drugs. 9:2831–2853. 2000. View Article : Google Scholar : PubMed/NCBI
5	Dong P, Kaneuchi M, Konno Y, Watari H, Sudo S and Sakuragi N: Emerging therapeutic biomarkers in endometrial cancer. Biomed Res Int. 2013:1303622013. View Article : Google Scholar : PubMed/NCBI
6	Gong B, Yue Y, Wang R, Zhang Y, Jin Q and Zhou X: Overexpression of microRNA-194 suppresses the epithelial-mesenchymal transition in targeting stem cell transcription factor Sox3 in endometrial carcinoma stem cells. Tumour Biol. 39:10104283177062172017. View Article : Google Scholar : PubMed/NCBI
7	Oyanadel C, Holmes C, Pardo E, Retamal C, Shaughnessy R, Smith P, Cortés P, Bravo-Zehnder M, Metz C, Feuerhake T, et al: Galectin-8 induces partial epithelial-mesenchymal transition with invasive tumorigenic capabilities involving a FAK/EGFR/proteasome pathway in Madin-Darby canine kidney cells. Mol Biol Cell. 29:557–574. 2018. View Article : Google Scholar : PubMed/NCBI
8	Meng X, Kong DH, Li N, Zong ZH, Liu BQ, Du ZX, Guan Y, Cao L and Wang HQ: Knockdown of BAG3 induces epithelial-mesenchymal transition in thyroid cancer cells through ZEB1 activation. Cell Death Dis. 5:e10922014. View Article : Google Scholar : PubMed/NCBI
9	Mitra A, Mishra L and Li S: EMT, CTCs and CSCs in tumor relapse and drug-resistance. Oncotarget. 6:10697–10711. 2015. View Article : Google Scholar : PubMed/NCBI
10	Huszar M, Pfeifer M, Schirmer U, Kiefel H, Konecny GE, Ben-Arie A, Edler L, Munch M, Muller-Holzner E, Jerabek-Klestil S, et al: Up-regulation of L1CAM is linked to loss of hormone receptors and E-cadherin in aggressive subtypes of endometrial carcinomas. J Pathol. 220:551–561. 2010. View Article : Google Scholar : PubMed/NCBI
11	Kent CN and Guttilla Reed IK: Regulation of epithelial-mesenchymal transition in endometrial cancer: Connecting PI3K, estrogen signaling, and microRNAs. Clin Transl Oncol. 18:1056–1061. 2016. View Article : Google Scholar : PubMed/NCBI
12	Prossnitz ER and Barton M: The G-protein-coupled estrogen receptor GPER in health and disease. Nat Rev Endocrinol. 7:715–726. 2011. View Article : Google Scholar : PubMed/NCBI
13	Molina L, Figueroa CD, Bhoola KD and Ehrenfeld P: GPER-1/GPR30 a novel estrogen receptor sited in the cell membrane: Therapeutic coupling to breast cancer. Expert Opin Ther Targets. 21:755–766. 2017. View Article : Google Scholar : PubMed/NCBI
14	Zhu P, Liao LY, Zhao TT, Mo XM, Chen GG and Liu ZM: GPER/ERK&AKT/NF-κB pathway is involved in cadmium-induced proliferation, invasion and migration of GPER-positive thyroid cancer cells. Mol Cell Endocrinol. 442:68–80. 2017. View Article : Google Scholar : PubMed/NCBI
15	Yan Y, Jiang X, Zhao Y, Wen H and Liu G: Role of GPER on proliferation, migration and invasion in ligand-independent manner in human ovarian cancer cell line SKOV3. Cell Biochem Funct. 33:552–559. 2015. View Article : Google Scholar : PubMed/NCBI
16	Zhang L, Li Y, Lan L, Liu R, Wu Y, Qu Q and Wen K: Tamoxifen has a proliferative effect in endometrial carcinoma mediated via the GPER/EGFR/ERK/cyclin D1 pathway: A retrospective study and an in vitro study. Mol Cell Endocrinol. 437:51–61. 2016. View Article : Google Scholar : PubMed/NCBI
17	Petrie WK, Dennis MK, Hu C, Dai D, Arterburn JB, Smith HO, Hathaway HJ and Prossnitz ER: G protein-coupled estrogen receptor-selective ligands modulate endometrial tumor growth. Obstet Gynecol Int. 2013:4727202013. View Article : Google Scholar : PubMed/NCBI
18	He YY, Cai B, Yang YX, Liu XL and Wan XP: Estrogenic G protein-coupled receptor 30 signaling is involved in regulation of endometrial carcinoma by promoting proliferation, invasion potential, and interleukin-6 secretion via the MEK/ERK mitogen-activated protein kinase pathway. Cancer Sci. 100:1051–1061. 2009. View Article : Google Scholar : PubMed/NCBI
19	Smith HO, Leslie KK, Singh M, Qualls CR, Revankar CM, Joste NE and Prossnitz ER: GPR30: A novel indicator of poor survival for endometrial carcinoma. Am J Obstet Gynecol. 196:386.e1–e9.e11. 2007. View Article : Google Scholar
20	Fan DX, Yang XH, Li YN and Guo L: 17β-estradiol on the expression of G-protein coupled estrogen receptor (GPER/GPR30) mitophagy, and the PI3K/Akt signaling pathway in ATDC5 chondrocytes in vitro. Med Sci Monit. 24:1936–1947. 2018. View Article : Google Scholar : PubMed/NCBI
21	Zhang L, Zhao Y and Guo L: 17β-estradiol protects INS-1 insulinoma cells from mitophagy via G protein-coupled estrogen receptors and the PI3K/Akt signaling pathway. Int J Mol Med. 41:2839–2846. 2018.PubMed/NCBI
22	Bhaskaran M and Mohan M: MicroRNAs: History, biogenesis, and their evolving role in animal development and disease. Vet Pathol. 51:759–774. 2014. View Article : Google Scholar : PubMed/NCBI
23	Tsukamoto O, Miura K, Mishima H, Abe S, Kaneuchi M, Higashijima A, Miura S, Kinoshita A, Yoshiura K and Masuzaki H: Identification of endometrioid endometrial carcinoma-associated microRNAs in tissue and plasma. Gynecol Oncol. 132:715–721. 2014. View Article : Google Scholar : PubMed/NCBI
24	Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI
25	Drzewiecka-Jędrzejczyk M, Wlazeł R, Terlecka M and Jabłoński S: Serum metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 in lung carcinoma patients. J Thorac Dis. 9:5306–5313. 2017. View Article : Google Scholar : PubMed/NCBI
26	Bourboulia D and Stetler-Stevenson WG: Matrix metalloproteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs): Positive and negative regulators intumor cell adhesion. Semin Cancer Biol. 20:161–168. 2010. View Article : Google Scholar : PubMed/NCBI
27	Tang T, Shan G and Zeng F: Knockdown of DGCR5 enhances the radiosensitivity of human laryngeal carcinoma cells via inducing miR-195. J Cell Physiol. 234:12918–12925. 2019. View Article : Google Scholar : PubMed/NCBI
28	Yu W, Liang X, Li X, Zhang Y, Sun Z, Liu Y and Wang J: MicroRNA-195: A review of its role in cancers. Onco Targets Ther. 11:7109–7123. 2018. View Article : Google Scholar : PubMed/NCBI
29	Zhang J and Li W: Long noncoding RNA CYTOR sponges miR-195 to modulate proliferation, migration, invasion and radiosensitivity in nonsmall cell lung cancer cells. Biosci Rep. 38(pii): BSR201815992018. View Article : Google Scholar : PubMed/NCBI
30	Wang Y, Chen H, Fu Y, Ai A, Xue S, Lyu Q and Kuang Y: MiR-195 inhibits proliferation and growth and induces apoptosis of endometrial stromal cells by targeting FKN. Int J Clin Exp Pathol. 6:2824–2834. 2013.PubMed/NCBI
31	Kong F, Ma J, Yang H, Yang D, Wang C and Ma X: Long non-coding RNA PVT1 promotes malignancy in human endometrial carcinoma cells through negative regulation of miR-195-5p. Biochim Biophys Acta Mol Cell Res. Jul 19–2018.doi: 10.1016/j.bbamcr.2018.07.008 (Epub ahead of print). View Article : Google Scholar : PubMed/NCBI
32	Segarra J, Balenci L, Drenth T, Maina F and Lamballe F: Combined signaling through ERK, PI3K/AKT, and RAC1/p38 is required for met-triggered cortical neuron migration. J Biol Chem. 281:4771–4778. 2006. View Article : Google Scholar : PubMed/NCBI
33	Tian PC, Wang HL, Chen GH, Luo Q, Chen Z, Wang Y and Liu YF: 2,2′,4,4′-Tetrabromodiphenyl ether promotes human neuroblastoma SH-SY5Y cells migration via the GPER/PI3K/Akt signal pathway. Hum Exp Toxicol. 35:124–134. 2016. View Article : Google Scholar : PubMed/NCBI
34	Ulrich LS: Endometrial cancer, types, prognosis, female hormones and antihormones. Climacteric. 14:418–425. 2011. View Article : Google Scholar : PubMed/NCBI
35	Geletina NS, Kobelev VS, Babayants EV, Feng L, Pustylnyak VO and Gulyaeva LF: PTEN negative correlates with miR-181a in tumour tissues of non-obese endometrial cancer patients. Gene. 655:20–24. 2018. View Article : Google Scholar : PubMed/NCBI
36	Yin H, Zhu Q, Liu M, Tu G, Li Q, Yuan J, Wen S and Yang G: GPER promotes tamoxifen-resistance in ER+ breast cancer cells by reduced Bim proteins through MAPK/Erk-TRIM2 signaling axis. Int J Oncol. 51:1191–1198. 2017. View Article : Google Scholar : PubMed/NCBI
37	Li Y, Birnbaumer L and Teng CT: Regulation of ERRalpha gene expression by estrogen receptor agonists and antagonists in SKBR3 breast cancer cells: Differential molecular mechanisms mediated by g protein-coupled receptor GPR30/GPER-1. Mol Endocrinol. 24:969–980. 2010. View Article : Google Scholar : PubMed/NCBI
38	He YY, Du GQ, Cai B, Yan Q, Zhou L, Chen XY, Lu W, Yang YX and Wan XP: Estrogenic transmembrane receptor of GPR30 mediates invasion and carcinogenesis by endometrial cancer cell line RL95-2. J Cancer Res Clin Oncol. 138:775–783. 2012. View Article : Google Scholar : PubMed/NCBI
39	Guan BZ, Yan RL, Huang JW, Li FL, Zhong YX, Chen Y, Liu FN, Hu B, Huang SB and Yin LH: Activation of G protein coupled estrogen receptor (GPER) promotes the migration of renal cell carcinoma via the PI3K/AKT/MMP-9 signals. Cell Adh Migr. 12:109–117. 2018. View Article : Google Scholar : PubMed/NCBI